Atossa Therapeutics announced its expected upcoming inclusion in the Russell 3000 Index, according to preliminary Russell reconstruction information posted on the FTSE Russell website. The newly reconstructed index will take effect after the market closes on June 28, 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATOS:
- Atossa Set to Join Russell 3000® Index Effective June 28, 2024
- Atossa to Present at the Sidoti Small-Cap Investor Conference
- Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model
- Atossa Therapeutics announces support for Phase 2 SMART study
- Atossa announces last patient, last dose in Phase 2 Karisma-Endoxifen trial